Want to see PODD full AI Analyst Report?
Compare Insulet (PODD) vs. Competitors
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| PODDInsulet | $149.68 | $10.38B | 27.93 | -52.02% | Moderate Buy | PODD | ||||
| ABTAbbott Laboratories | $106.20 | $183.77B | 39.33 | -14.82% | Strong Buy | PODD vs ABT | ||||
| DXCMDexcom | $82.29 | $30.69B | 31.77 | 20.66% | Strong Buy | PODD vs DXCM | ||||
| MDTMedtronic | $96.54 | $123.49B | 23.60 | 6.12% | Moderate Buy | PODD vs MDT | ||||
| TNDMTandem Diabetes Care | $19.11 | $1.33B | -20.58 | 30.98% | Moderate Buy | PODD vs TNDM | ||||
| BBNXBeta Bionics, Inc. | $16.75 | $910.65M | -8.96 | -37.45% | Moderate Buy | PODD vs BBNX |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| PODD | Insulet | 149.68 | -169.09 | -53.04% | |
| ABT | Abbott Laboratories | 106.20 | -14.64 | -12.11% | |
| DXCM | Dexcom | 82.29 | 21.86 | 36.17% | |
| MDT | Medtronic | 96.54 | 9.23 | 10.58% | |
| TNDM | Tandem Diabetes Care | 19.11 | 4.75 | 33.08% | |
| BBNX | Beta Bionics, Inc. | 16.75 | -10.95 | -39.53% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts